GleamWall
中文EN

PDEX PRO DEX INC

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 788920 · Fiscal year ends 06/30

Financial factors as of 2026-09-30 (2027Q1), TTM = sum of the last four quarters

Growth

TTM revenue YoY13.3%
TTM net income YoY7.5%
TTM EPS YoY9.6%
Revenue 3-yr CAGR19.2%
Net income 3-yr CAGR16.7%

Margins

Gross margin32.5%
Operating margin16.8%
Net margin15.1%
FCF margin13.4%
EBITDA margin18.7%

Returns

ROE26.5%
ROA17.1%
ROIC (approx.)27.0%
Asset turnover1.13x

Leverage & solvency

Liabilities / assets35.6%
Debt / equity0.00x
Current ratio4.19x
Interest coverage15.36x

Cash quality & payout

Operating cash flow / net income0.95x
Accruals ratio0.9%
Payout ratio—
Capex / revenue0.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20262026-06-30FY20252025-06-30FY20242024-06-30FY20232023-06-30FY20222022-06-30
Income statement
Revenue$77.55M$66.59M$53.84M$46.09M$42.04M
Cost of revenue$53.21M$47.08M$39.29M$33.34M$28.91M
Gross profit$24.34M$19.51M$14.55M$12.75M$13.13M
R&D expense$3.35M$3.64M$3.19M$2.80M$2.98M
SG&A expense$8.00M$5.18M$4.07M$4.03M$4.90M
Operating income$12.99M$10.69M$7.17M$5.76M$5.12M
Interest expense$812,000$829,000$558,000$533,000$464,000
Pretax income$18.02M$12.06M$2.63M$9.43M$5.69M
Income tax$4.35M$3.08M$507,000$2.35M$1.12M
Net income$13.66M$8.98M$2.13M$7.07M$4.57M
EBITDA$14.38M$11.93M$8.33M$6.62M$5.85M
EPS (basic)4.242.730.611.981.26
EPS (diluted)4.122.670.601.951.21
Weighted avg. shares (diluted)3.32M3.36M3.57M3.64M3.76M
Balance sheet
Cash & equivalents$8.19M$419,000$2.63M$2.94M$849,000
Short-term investments$1.15M$6.74M$4.22M$1.13M$755,000
Receivables$21.20M$16.43M$13.89M$9.95M$15.38M
Inventory$21.46M$22.21M$15.27M$16.17M$12.68M
Current assets$53.25M$47.30M$36.61M$30.98M$31.17M
PP&E, net$5.37M$5.15M$5.02M$5.08M$4.83M
Goodwill$6.53M————
Intangibles$686,000$26,000$54,000$81,000$118,000
Total assets$74.51M$61.19M$52.48M$51.82M$49.09M
Current liabilities$12.98M$14.63M$12.89M$9.68M$11.35M
Long-term debt$17.51M$15.43M$11.96M$12.80M$13.59M
Total debt$17.51M$15.43M$11.96M$12.80M$13.59M
Total liabilities$26.88M$24.56M$21.61M$20.23M$23.66M
Shareholders' equity$47.63M$36.63M$30.87M$31.59M$25.43M
Net debt$9.32M$15.01M$9.32M$9.86M$12.74M
Shares outstanding3.19M3.26M3.36M3.55M3.60M
Cash flow statement
Operating cash flow$7.24M-$1.68M$6.22M$5.46M-$847,000
Capital expenditure$483,000$1.25M——$1.64M
Free cash flow$6.76M-$2.93M——-$2.48M
Investing cash flow$3.91M-$238,000-$2.23M-$885,000-$1.24M
Financing cash flow-$3.38M-$292,000-$4.30M-$2.49M-$790,000
Depreciation & amortization$1.39M$1.24M$1.16M$857,000$726,000
Stock-based compensation$688,000$555,000$605,000$766,000$1.27M
Share buybacks$3.41M$3.50M$3.50M$1.55M$1.61M

Free plan shows the latest 5 periods; Pro shows all 16 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-19 06:28.